James Aggen, a professor in the College of Science and Bouve College of Health Sciences, describes his to work to develop antidotes for multidrug-resistant (MDR) Gram-negative bacterial infections.
Alexander R. Ivanov, research associate professor in the Barnett Institute of Chemical and Biological Analysis, has received a research award from the American Society for Mass Spectrometry. The award, one of only two given each year, provides a financial grant to young scientists to promote academic research in mass spectrometry.
Northeastern’s chemistry department was recently ranked in the top 10 in a review of career support services among American chemistry departments.
The prevailing view of research science is that professors and laboratory staff work on obscure challenges for which a lifetime might not be enough time to solve. Or that their projects might have limited application in the ‘real’ world. If that’s how you think, you haven’t met Dr. Barry Karger.
Dr. William Hancock, the Bradstreet Chair in Chemistry and Chemical Biology and an expert in protein drugs, has been invited to serve as a consultant as a consultant to the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology in the Center for Drug Evaluation and Research (CDER) at the Food and Drug Administration (FDA).
Murray Gibson has decided to step down as the Dean of the College of Science, effective June 30, 2015. Murray’s tenure completes five years as the Founding Dean of the College of Science.
by Emily Ashbolt, Biomedical Physics, 2017 For the past decade, Northeastern University Chemistry and Chemical Biology professor Penny Beuning has focused her research on cellular responses to DNA damage, specifically a family of DNA polymerases that deal with copying the damaged DNA. Her tireless work in this area of chemistry has earned her the Chemical Research […]
The 2015 “Huntington 100″ list has been announced.
Chemistry major Shores Salter, who was recognized Thursday night at the Student Life Awards ceremony, reflects on the unbreakable bond he’s formed with Roseann Sdoia, a Boston Marathon bombing victim whose life he helped to save.
Northeastern University researchers have extensively profiled the proteins of rare cells in blood, a feat that was previously impossible. By successfully isolating and characterizing rare cells that make up just 0.001 percent or less of the total cells present in blood, faculty members have built a foundation for proteomics-based personalized medicine.